Results 161 to 170 of about 14,448 (252)
This review systematically elucidates the multifactorial anti‐aging mechanisms of extracellular vesicles (EVs). By bridging fundamental biology with advanced bioengineering, scalable manufacturing, and clinical translation, it establishes a comprehensive framework for developing next‐generation EVs‐based precision nanotherapeutics to combat systemic ...
Xian Huang +6 more
wiley +1 more source
NanoBind: Mechanism-Driven Deep Learning of Nanobody-Antigen Molecular Recognition. [PDF]
Zhao S +10 more
europepmc +1 more source
The extracellular matrix (ECM) is a dynamic scaffold that orchestrates tissue architecture and cellular communication. A critical but underexplored interplay between proteases and cluster of differentiation molecules (CD) governs ECM turnover and directs cell fate.
David Jurnečka +3 more
wiley +1 more source
Revisiting the Antigen 85 Complex as a Target for Functional Antibody-Based Strategies Against <i>Mycobacterium tuberculosis</i>. [PDF]
Smekenov I +3 more
europepmc +1 more source
Affinity Enhancement in Discrete Multivalent MegaMolecules
We design discrete protein megamolecules with precisely controlled valency (1–6 nanobodies), which exhibit strong avidity‐driven affinity enhancement toward epidermal growth factor receptor and human epidermal growth factor receptor. We systematically investigate the roles of valency, intrinsic affinity, and spatial presentation in optimizing binding ...
Zhaoyi Gu +7 more
wiley +1 more source
Nanobody-based analysis of RhoGTPase stress response in <i>Schizosaccharomyces pombe</i>: Role of <i>mtl</i>2. [PDF]
Rasheed N +4 more
europepmc +1 more source
G protein‐coupled receptors (GPCRs) are major therapeutic targets. Modulating GPCR activity through intracellular sites is evolving. A structure‐ and computation‐assisted approach generated small G protein‐derived peptidomimetics targeting the intracellular binding crevice of the β2 adrenergic receptor mimicking features of the full G protein.
Phuong Thu Tran +11 more
wiley +1 more source
Generation of Synthetic Acinetobacter baumannii-Specific Nanobodies
The bacterial pathogen Acinetobacter baumannii is a leading cause of drug-resistant infections. Here, we investigated the potential of developing nanobodies that can recognize A. baumannii over other Gram-negative bacteria. Through generation and panning
Gregory A. Knauf (15446313) +3 more
core +1 more source
Functional Suitability Evaluation of Radioimmunoconjugates of Nanobodies against PD-L1 and HER2/neu for Tumor Theranostics. [PDF]
Avrov KO +9 more
europepmc +1 more source
Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape. [PDF]
Bu F +13 more
europepmc +1 more source

